Your browser doesn't support javascript.
loading
Construction and validation of a TP53-associated immune prognostic model for gastric cancer.
Nie, Kechao; Zheng, Zhihua; Wen, Yi; Shi, Laner; Xu, Shjie; Wang, Xueqi; Zhou, Yingsheng; Fu, Bin; Li, Xiushen; Deng, Zhitong; Pan, Jinglin; Jiang, Xiaotao; Jiang, Kailin; Yan, Yanhua; Zhuang, Kunhai; Huang, Wei; Liu, Fengbin; Li, Peiwu.
Affiliation
  • Nie K; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China; Department of Integrated Traditional Chinese & Western Medicine, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • Zheng Z; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Wen Y; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Shi L; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Xu S; Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Wang X; Department of The Spleen and Stomach, Qingyuan Traditional Chinese Medicine Hospital, Qingyuan 511500, Guangdong, China.
  • Zhou Y; University of Chinese Academy of Sciences-Shenzhen Hospital, Shenzhen, Guangdong, China.
  • Fu B; Hospital of Traditional Chinese Medicine of Zhongshan, Zhongshan 528400, China.
  • Li X; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Deng Z; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Pan J; Department of Gastroenterology, Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou, Hainan, China.
  • Jiang X; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Jiang K; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Yan Y; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
  • Zhuang K; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China. Electronic address: sea-zhuang007@163.com.
  • Huang W; Department of Integrated Traditional Chinese & Western Medicine, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China. Electronic address: huangweidavid@csu.edu.cn.
  • Liu F; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China. Electronic address: liufb163@vip163.com.
  • Li P; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China. Electronic address: doctorlipw@gzucm.edu.cn.
Genomics ; 112(6): 4788-4795, 2020 11.
Article in En | MEDLINE | ID: mdl-32858135

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Immunophenotyping / Tumor Suppressor Protein p53 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Genomics Journal subject: GENETICA Year: 2020 Document type: Article Affiliation country: China Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Immunophenotyping / Tumor Suppressor Protein p53 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Genomics Journal subject: GENETICA Year: 2020 Document type: Article Affiliation country: China Country of publication: United States